Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer

被引:130
|
作者
Jiang, Meng [1 ]
Li, Chang-Li [2 ]
Luo, Xiao-Mao [3 ,4 ]
Chuan, Zhi-Rui [3 ,4 ]
Lv, Wen-Zhi [5 ]
Li, Xu [6 ]
Cui, Xin-Wu [1 ]
Dietrich, Christoph F. [7 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Med Ultrasound, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China
[2] Hubei Prov Hosp Integrated Chinese & Western Med, Dept Geratol, 11 Lingjiaohu Ave, Wuhan 430015, Peoples R China
[3] Kunming Med Univ, Dept Med Ultrasound, Yunnan Canc Hosp, Kunming 650118, Yunnan, Peoples R China
[4] Kunming Med Univ, Affiliated Hosp 3, Kunming 650118, Yunnan, Peoples R China
[5] Julei Technol, Dept Artificial Intelligence, Wuhan 430030, Peoples R China
[6] South Cent Univ Nationalities, Sch Biomed Engn, 182 Minyuan Rd, Wuhan 430074, Peoples R China
[7] Hirslanden Clin, Dept Internal Med, Schanzlihalde 11, CH-3013 Bern, Switzerland
基金
中国博士后科学基金;
关键词
PPathological complete response; DDeep learning; RRadiomic nomogram; Locally advanced breast cancer; PREDICTION; ESTROGEN; NOMOGRAM; MRI;
D O I
10.1016/j.ejca.2021.01.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of the study was to develop and validate a deep learning radiomic nomogram (DLRN) for preoperatively assessing breast cancer pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) based on the pre- and post-treatment ultrasound. Methods: Patients with locally advanced breast cancer (LABC) proved by biopsy who proceeded to undergo preoperative NAC were enrolled from hospital #1 (training cohort, 356 cases) and hospital #2 (independent external validation cohort, 236 cases). Deep learning and handcrafted radiomic features reflecting the phenotypes of the pre- treatment (radiomic signature [RS] 1) and post-treatment tumour (RS2) were extracted. The minimum redundancy maximum relevance algorithm and the least absolute shrinkage and selection operator regression were used for feature selection and RS construction. A DLRN was then developed based on the RSs and independent clinicopathological risk factors. The performance of the model was assessed with regard to calibration, discrimination and clinical usefulness. Results: The DLRN predicted the pCR status with accuracy, yielded an area under the receiver operator characteristic curve of 0.94 (95% confidence interval, 0.91-0.97) in the validation cohort, with good calibration. The DLRN outperformed the clinical model and single RS within both cohorts (P < 0.05, as per the DeLong test) and performed better than two experts' prediction of pCR (both P < 0.01 for comparison of total accuracy). Besides, prediction within the hormone receptor-positive/human epidermal growth factor receptor 2 (HER2)-negative, HER2+ and triple-negative subgroups also achieved good discrimination performance, with an AUC of 0.90, 0.95 and 0.93, respectively, in the external validation cohort. Decision curve analysis confirmed that the model was clinically useful. Conclusion: A deep learning-based radiomic nomogram had good predictive value for pCR in LABC, which could provide valuable information for individual treatment. (C) 2021 Elsevier Ltd. All rights reserved.
引用
收藏
页码:95 / 105
页数:11
相关论文
共 50 条
  • [31] Do responses in PET/CT correlate with pathological complete response after neoadjuvant chemotherapy in locally advanced breast cancer?
    Kaya, Serap
    Simsek, Eda Tanrikulu
    Ugurlu, Umit
    Ozgen, Zerrin
    Halil, Suleyman
    Besiroglu, Mehmet
    Koca, Sinan
    Babacan, Nalan
    Dane, Faysal
    Kaya, Handan
    Turhal, Serdar
    Yumuk, Fulden
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Estrogen Receptor Expression: Possible Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
    Wu, J.
    Shen, K.
    Chen, X.
    Chen, C.
    Hu, Z.
    Liu, G.
    Di, G.
    Lu, J.
    Wu, J.
    Shao, Z.
    Shen, Z.
    CANCER RESEARCH, 2009, 69 (24) : 572S - 572S
  • [33] CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
    Furlan Matos Alves, Wilson Eduardo
    Bonatelli, Murilo
    Dufloth, Rozany
    Kerr, Ligia Maria
    Angotti Carrara, Guilherme Freire
    Alves da Costa, Ricardo Filipe
    Scapulatempo-Neto, Cristovam
    Tiezzi, Daniel
    da Costa Vieira, Rene Aloisio
    Pinheiro, Celine
    BMC CANCER, 2019, 19 (01)
  • [34] Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
    Shimamaki, Yoshitaka
    Hosokawa, Isamu
    Takayashiki, Tsukasa
    Takano, Shigetsugu
    Sonoda, Itaru
    Ohtsuka, Masayuki
    SURGICAL CASE REPORTS, 2024, 10 (01)
  • [35] Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
    Yoshitaka Shimamaki
    Isamu Hosokawa
    Tsukasa Takayashiki
    Shigetsugu Takano
    Itaru Sonoda
    Masayuki Ohtsuka
    Surgical Case Reports, 10
  • [36] Occult breast cancer with pathological complete response to neoadjuvant chemotherapy
    Ren, Ningning
    Liu, Shuo
    Shi, Peng
    Tian, Xingsong
    ASIAN JOURNAL OF SURGERY, 2024, 47 (11) : 4949 - 4951
  • [37] Deep learning Radiomics Based on Two-Dimensional Ultrasound for Predicting the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer
    Wang, Zhan
    Li, Xiaoqin
    Zhang, Heng
    Duan, Tongtong
    Zhang, Chao
    Zhao, Tong
    ULTRASONIC IMAGING, 2024, 46 (06) : 357 - 366
  • [38] MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
    Choudhery, Sadia
    Gomez-Cardona, Daniel
    Favazza, Christopher P.
    Hoskin, Tanya L.
    Haddad, Tufia C.
    Goetz, Matthew P.
    Boughey, Judy C.
    ACADEMIC RADIOLOGY, 2022, 29 : S145 - S154
  • [39] Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer
    Fengling Li
    Yongquan Yang
    Yani Wei
    Ping He
    Jie Chen
    Zhongxi Zheng
    Hong Bu
    Journal of Translational Medicine, 19
  • [40] Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer
    Li, Fengling
    Yang, Yongquan
    Wei, Yani
    He, Ping
    Chen, Jie
    Zheng, Zhongxi
    Bu, Hong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)